| The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda. | |
| | |
MedLine Citation:
|
PMID: 17243426 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Various factors contribute to the development of porphyria cutanea tarda (PCT). In this case report, we describe a patient with hepatitis C infection and chronic renal failure. The individual mechanisms, which promote cutaneous disease, are discussed. Finally, we propose that each factor may have an additive effect in prolonging the skin lesions of PCT. |
| | |
Authors:
|
Owen T M Chan; Naoky Tsai; Ramona L Wong; Allan K Izumi |
Related Documents
:
|
15115956 - Transthyretin familial amyloidotic polyneuropathy: histopathological study of the expla... 18294936 - Acute liver and renal failure during treatment with buprenorphine at therapeutic dose. 11776146 - Two cases of combined liver-kidney transplantation. 12605646 - The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia. 20087256 - Public health aspects of renal diseases in the republic of macedonia 1983-2007. 3887906 - Mechanisms of posttransplant hypertension. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cutis; cutaneous medicine for the practitioner Volume: 78 ISSN: 0011-4162 ISO Abbreviation: Cutis Publication Date: 2006 Dec |
Date Detail:
|
Created Date: 2007-01-24 Completed Date: 2007-02-22 Revised Date: 2009-11-11 |
Medline Journal Info:
|
Nlm Unique ID: 0006440 Medline TA: Cutis Country: United States |
Other Details:
|
Languages: eng Pagination: 397-400 Citation Subset: IM |
Affiliation:
|
University of Hawaii, Honolulu, HI, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Bacterial Agents
/
therapeutic use Cephalexin / therapeutic use Hepatitis C, Chronic / complications* Humans Iron Overload / complications, etiology, prevention & control Kidney Failure, Chronic / complications* Male Middle Aged Phlebotomy* Porphyria Cutanea Tarda / drug therapy, etiology*, physiopathology Uroporphyrins / adverse effects* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/Uroporphyrins; 15686-71-2/Cephalexin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Profitability starts within.
Next Document: Atopic dermatitis in children, part 2: treatment options.